Ashkenazi A - Search Results

1

Proapoptotic DR4 and DR5 signaling in cancer cells: toward clinical translation.

Yang A, Wilson NS, Ashkenazi A. Yang A, et al. Among authors: ashkenazi a. Curr Opin Cell Biol. 2010 Dec;22(6):837-44. doi: 10.1016/j.ceb.2010.08.001. Epub 2010 Aug 31. Curr Opin Cell Biol. 2010. PMID: 20813513 Review.

2

Death receptor signal transducers: nodes of coordination in immune signaling networks.

Wilson NS, Dixit V, Ashkenazi A. Wilson NS, et al. Among authors: ashkenazi a. Nat Immunol. 2009 Apr;10(4):348-55. doi: 10.1038/ni.1714. Epub 2009 Mar 19. Nat Immunol. 2009. PMID: 19295631 Review.

3

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.

Wilson NS, Yang B, Yang A, Loeser S, Marsters S, Lawrence D, Li Y, Pitti R, Totpal K, Yee S, Ross S, Vernes JM, Lu Y, Adams C, Offringa R, Kelley B, Hymowitz S, Daniel D, Meng G, Ashkenazi A. Wilson NS, et al. Among authors: ashkenazi a. Cancer Cell. 2011 Jan 18;19(1):101-13. doi: 10.1016/j.ccr.2010.11.012. Cancer Cell. 2011. PMID: 21251615 Free article.

4

ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway.

Wilson NS, Yang B, Morelli AB, Koernig S, Yang A, Loeser S, Airey D, Provan L, Hass P, Braley H, Couto S, Drane D, Boyle J, Belz GT, Ashkenazi A, Maraskovsky E. Wilson NS, et al. Among authors: ashkenazi a. Immunol Cell Biol. 2012 May;90(5):540-52. doi: 10.1038/icb.2011.71. Epub 2011 Sep 6. Immunol Cell Biol. 2012. PMID: 21894173 Free PMC article.

5

Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth.

Wilson NS, Yang A, Yang B, Couto S, Stern H, Gogineni A, Pitti R, Marsters S, Weimer RM, Singh M, Ashkenazi A. Wilson NS, et al. Among authors: ashkenazi a. Cancer Cell. 2012 Jul 10;22(1):80-90. doi: 10.1016/j.ccr.2012.05.014. Cancer Cell. 2012. PMID: 22789540 Free article.

6

Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages.

Chaudhuri A, Wilson NS, Yang B, Paler Martinez A, Liu J, Zhu C, Bricker N, Couto S, Modrusan Z, French D, Cupp J, Ashkenazi A. Chaudhuri A, et al. Among authors: ashkenazi a. Immunol Cell Biol. 2013 Aug;91(7):451-60. doi: 10.1038/icb.2013.27. Epub 2013 Jul 2. Immunol Cell Biol. 2013. PMID: 23817579 Free PMC article.

7

Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvant.

Wilson NS, Duewell P, Yang B, Li Y, Marsters S, Koernig S, Latz E, Maraskovsky E, Morelli AB, Schnurr M, Ashkenazi A. Wilson NS, et al. Among authors: ashkenazi a. J Immunol. 2014 Apr 1;192(7):3259-68. doi: 10.4049/jimmunol.1302011. Epub 2014 Mar 7. J Immunol. 2014. PMID: 24610009

8

Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists.

Li B, Russell SJ, Compaan DM, Totpal K, Marsters SA, Ashkenazi A, Cochran AG, Hymowitz SG, Sidhu SS. Li B, et al. Among authors: ashkenazi a. J Mol Biol. 2006 Aug 18;361(3):522-36. doi: 10.1016/j.jmb.2006.06.042. Epub 2006 Jul 7. J Mol Biol. 2006. PMID: 16859704

9

Targeting death receptors in cancer with Apo2L/TRAIL.

Kelley SK, Ashkenazi A. Kelley SK, et al. Among authors: ashkenazi a. Curr Opin Pharmacol. 2004 Aug;4(4):333-9. doi: 10.1016/j.coph.2004.02.006. Curr Opin Pharmacol. 2004. PMID: 15251125 Review.

10

Apoptosis control by death and decoy receptors.

Ashkenazi A, Dixit VM. Ashkenazi A, et al. Curr Opin Cell Biol. 1999 Apr;11(2):255-60. doi: 10.1016/s0955-0674(99)80034-9. Curr Opin Cell Biol. 1999. PMID: 10209153 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page